Future randomized controlled trials with larger sample sizes are needed to confirm the causal relationship between GLP-1RA treatment and changes in sCD36 levels.7, Although sCD36 has been shown in previous studies to correlate with renal CD36 expression and injury in DKD models, it is important to note that sCD36 is not renal-specific. Here, CD36 is linked to diabetic kidney disease.